证券日报网讯爱迪特（301580）8月27日发布公告，在公司回答调研者提问时表示，口腔数字化设备收 入贡献0.96亿元，同比增长3.64%；因公司设备自产，产品竞争力有一定程度的提高，2025年上半年数 字化设备产品单价和毛利率均有所提升。3D打印业务继年初新品发布后，5月份开始也出现订单的小高 峰，目前销售情况基本与公司预期相符，同时公司冠桥打印树脂成功获得美国FDA认证，全口活动义齿 打印/种植即刻负重临时牙方案也获得了市场验证，成功在合作加工厂客户处完成上百例成功验证。 ...

根据公司披露的2025年半年度报告，上半年实现营业收入4.86亿元，同比增长17.22%；归母净利润 9204.32万元，同比增长19.86%。公司经营活动产生的现金流量净额为7915.34万元，同比增长 141.72%。此外，公司计划投资2000万元在杭州设立全资子公司，拓展技术服务、软件开发等业务领 域。 截至2025年8月25日15时，爱迪特最新股价为50.20元，较前一交易日上涨0.36%。当日成交量为34573 手，成交额达1.73亿元。 风险提示：以上内容仅供参考，不构成投资建议。市场有风险，投资需谨慎。 爱迪特属于医疗器械板块，是国内领先的口腔修复材料及口腔数字化设备提供商。公司主营业务包括口 腔修复材料、口腔数字化设备等产品的研发、生产和销售。 数据显示，爱迪特8月25日主力资金净流入431.29万元，近五日主力资金净流入183.67万元。 ...

数字化设备业务方面，公司实现营业收入0.96亿元，同比增长3.64%，占公司整体营业收入的19.80%。 公司通过持续推进产品迭代、优化产品结构、精细化运营管理等举措，推动盈利能力稳步提升，报告期 内该业务毛利率达30.50%，同比提升1.24%。 多因素促公司经营稳定增长 上半年公司持续投入研发，研发费用达2825.5万元，同比增长36.12%。通过持续的研发投入，公司围绕 口腔产业链上下游形成了以新型口腔修复材料、数字化设备、口腔种植系统、数字化全口义齿、口腔正 畸、口腔预防等产品研发体系。公司两大主营板块口腔数字化设备业务与口腔修复材料形成协同效应， 为客户构建降本增效的产品和服务体系，显著提升其市场竞争力。 在立足国内市场的同时，公司积极布局海外市场。公司在欧美、日韩等成熟市场建立了子公司，通过本 地化运营提升了品牌知名度和客户满意度，海外市场成为公司业绩增长的重要驱动力。与此同时，公司 还积极开拓东南亚、中东和澳洲等口腔医疗器械领域的新兴市场。(燕云) 爱迪特（301580）8月25日晚发布2025年半年度报告，公司上半年实现营业和利润双位数增长。在人口 老龄化与人们口腔健康意识持续提升的背景下，公 ...

Group 1 - The core viewpoint of the articles highlights the performance and market position of Aidi Te (爱迪特) in the medical device industry, noting its recent stock decline and financial metrics [1][2] - Aidi Te's closing stock price on July 29 was 53.41 yuan, reflecting a decrease of 6.30%, with a rolling PE ratio of 35.92 times and a total market capitalization of 5.692 billion yuan [1] - In comparison to the industry, Aidi Te's PE ratio is below the average of 55.46 times and the median of 37.74 times, ranking 70th in the industry [1][2] Group 2 - The company reported a revenue of 205 million yuan for Q1 2025, representing a year-on-year increase of 18.07%, and a net profit of 31.27 million yuan, up 34.21% year-on-year, with a gross margin of 51.00% [1] - On July 29, Aidi Te experienced a net outflow of 50.19 million yuan in principal funds, although it had a total inflow of 59.42 million yuan over the past five days [1]

Company Overview - Aidi Te (Qinhuangdao) Technology Co., Ltd. specializes in the research, production, and sales of dental restoration materials and digital dental equipment [1] - The main products include dental restoration materials and digital dental equipment [1] Financial Performance - For Q1 2025, the company reported revenue of 205 million yuan, representing a year-on-year increase of 18.07% [1] - The net profit for the same period was 31.27 million yuan, showing a year-on-year growth of 34.21% [1] - The gross profit margin was recorded at 51.00% [1] Market Position - As of July 24, the closing price of Aidi Te was 49.85 yuan, with a 4.60% increase [1] - The rolling price-to-earnings (PE) ratio reached 33.52, marking a new low in 34 days [1] - The total market capitalization of the company is 5.312 billion yuan [1] Shareholder Information - As of March 31, 2025, the number of shareholders was 8,036, a decrease of 548 from the previous count [1] - The average market value of shares held by each shareholder is 352,800 yuan, with an average holding of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 54.55, while the median is 37.54 [2] - Aidi Te ranks 69th in terms of PE ratio within its industry [1][2]

Core Viewpoint - Aidi Tech's stock closed at 45.2 yuan on July 18, with a 4.27% increase, and its rolling PE ratio reached a new low of 30.40 times over the past 30 days, with a total market value of 4.817 billion yuan [1] Company Summary - Aidi Tech specializes in the research, production, and sales of dental restoration materials and digital dental equipment, with its main products being dental restoration materials and digital dental devices [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 205 million yuan, a year-on-year increase of 18.07%, and a net profit of 31.2714 million yuan, a year-on-year increase of 34.21%, with a gross profit margin of 51.00% [1] Industry Summary - The average PE ratio for the medical device industry is 52.34 times, with a median of 36.99 times, placing Aidi Tech at the 65th position in the industry ranking [1] - Aidi Tech's PE (TTM) is 30.40, while the industry average PE (TTM) is 52.34, indicating that Aidi Tech's valuation is below the industry average [2] - The total market value of Aidi Tech is 4.817 billion yuan, compared to the industry median market value of 51.28 billion yuan [2]

Company Overview - Aidi Te (Qinhuangdao) Technology Co., Ltd. specializes in the research, production, and sales of dental restoration materials and digital dental equipment [1] - The main products include dental restoration materials and digital dental equipment [1] Financial Performance - For Q1 2025, the company reported revenue of 205 million yuan, representing a year-on-year increase of 18.07% [1] - The net profit for the same period was 31.27 million yuan, showing a year-on-year growth of 34.21% [1] - The sales gross margin stood at 51.00% [1] Market Position - As of July 1, the company's stock closed at 40.89 yuan, down 1.30%, with a rolling price-to-earnings (PE) ratio of 27.50 times [1] - The total market capitalization is 4.357 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical device sector is 51.70 times, with a median of 37.36 times, placing Aidi Te at the 59th position in the industry ranking [1][2] Capital Flow - On July 1, the net inflow of main funds into Aidi Te was 382,900 yuan, with a total inflow of 18.7834 million yuan over the past five days [1]

Company Overview - Aidi Te (Qinhuangdao) Technology Co., Ltd. specializes in the research, production, and sales of dental restoration materials and digital dental equipment [1] - The main products include dental restoration materials and digital dental equipment [1] Financial Performance - For Q1 2025, the company reported revenue of 205 million yuan, representing a year-on-year increase of 18.07% [1] - The net profit for the same period was 31.27 million yuan, showing a year-on-year growth of 34.21% [1] - The gross profit margin stood at 51.00% [1] Market Position - As of June 9, Aidi Te's stock closed at 58.75 yuan, with a 6.01% increase [1] - The rolling price-to-earnings (PE) ratio reached 28.22, marking a new low in 104 days [1] - The company's total market capitalization is 4.472 billion yuan [1] Industry Comparison - The average PE ratio for the medical device industry is 50.64, while the industry median is 37.05 [2] - Aidi Te ranks 61st in terms of PE ratio within its industry [1][2] - The company's PE ratio is significantly lower than the industry average, indicating potential undervaluation [2] Shareholder Information - As of March 31, 2025, Aidi Te had 8,036 shareholders, a decrease of 548 from the previous count [1] - The average market value of shares held by each shareholder is 352,800 yuan, with an average holding of 27,600 shares [1]

Group 1 - The core viewpoint of the article highlights the performance and valuation of Aidi Te (爱迪特), indicating a recent stock price increase and a low rolling PE ratio compared to the industry average [1] - As of May 20, Aidi Te's closing price was 56.11 yuan, with a rolling PE ratio of 26.95, marking a new low in 31 days, and a total market capitalization of 4.271 billion yuan [1] - The company ranks 59th in the medical device industry, which has an average PE ratio of 49.51 and a median of 36.17 [2] Group 2 - Aidi Te experienced a net outflow of 351,100 yuan in principal funds on May 20, with a total outflow of 1.749 million yuan over the past five days [1] - The company's main business includes the research, production, and sales of dental restoration materials and the design and sales of dental digital equipment [1] - In the latest quarterly report for Q1 2025, Aidi Te achieved an operating income of 205 million yuan, a year-on-year increase of 18.07%, and a net profit of 31.271 million yuan, reflecting a year-on-year growth of 34.21% with a gross profit margin of 51.00% [1]

Core Viewpoint - The company, Aidi Te (301580.SZ), is experiencing rapid business growth in the dental restoration materials and digital dental equipment sector, leveraging digitalization to connect clinical and technical aspects of dental services, while focusing on consumer needs [1][2]. Group 1: Financial Performance - In 2024, Aidi Te achieved a revenue of 888 million yuan, a year-on-year increase of 13.81% [1]. - The net profit attributable to shareholders was 150 million yuan, up 2.40% from the previous year, while the net profit after deducting non-recurring gains and losses was 145 million yuan, reflecting a growth of 9.32% [1]. - The company plans to distribute a cash dividend of 0.49 million yuan (including tax) and a capital reserve conversion of 30.45 million shares, with a cash dividend ratio of 32.88% of the annual net profit [1]. Group 2: Research and Development - Aidi Te invested 47.36 million yuan in R&D during the reporting period, marking an 18.21% increase year-on-year [2]. - The company has developed a comprehensive product R&D system covering various aspects of the dental industry, including new dental restoration materials and digital equipment [2]. - The synergy between the digital equipment and restoration materials enhances market competitiveness and promotes digital transformation in the traditional dental industry [2]. Group 3: Market Position and Growth Outlook - Aidi Te has established a strong presence in the domestic dental medical industry, with its products distributed across major provinces and cities in China, and has also made significant inroads into international markets [2]. - The company is expected to maintain a growth trajectory due to its leading position in dental restoration materials and digital equipment, supported by robust R&D and a global sales network [2]. - In Q1 2025, Aidi Te reported a revenue of 205 million yuan, an 18.07% increase year-on-year, and a net profit of 31.27 million yuan, reflecting a substantial growth of 34.21% [3]. - The company aims to enhance its growth-oriented business and improve operational efficiency through strategic planning and market expansion in 2025 [3].